Today: 18 June 2026
Browse Category

NASDAQ:CODX 27 October 2025 - 26 May 2026

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics Stock Surges on Ebola Test Push, But One Filing Shows the Catch

Co-Diagnostics shares surged 78% to $9.03 Tuesday after the company announced progress on a PCR test for the Bundibugyo Ebola strain amid a fast-spreading outbreak in central Africa. Over 46.5 million shares traded following news of the test, which is not yet approved for sale. The company recently raised $3 million in a private placement but reported a first-quarter net loss of $9.14 million and warned of “substantial doubt” about its ability to continue.
26 May 2026
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics shares surged 51% Tuesday after the company announced completion of an assay strategy for the Bundibugyo Ebola virus, though the test is not yet for sale and awaits regulatory approval. Trading volume topped 94 million shares. The company reported $8.23 million in cash at March 31 and a quarterly net loss of $9.14 million, raising concerns about its financial stability.
Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics shares soared 206% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests in Saudi Arabia and 18 other countries. Over 100 million shares traded amid the surge. The stock’s market cap jumped from about $18 million to as much as $60 million. The company reported just $200,000 in Q2 revenue and recently raised $3.8 million via stock sale.
Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics shares jumped over 200% to close at $1.07 on October 27 after announcing a joint venture with Arabian Eagle Manufacturing to distribute PCR tests across the Middle East and North Africa. Trading volume topped 100 million shares amid a surge in retail investor activity. The company recently reported Q2 revenue of $200,000, down sharply from the prior year. Analyst price targets ranged from $1.00 to $3.00.

Stock Market Today

  • AT&T Shares Dip Ahead of CFO Transition Amid Fiber Investment Concerns
    June 18, 2026, 9:48 AM EDT. AT&T Inc. shares fell in premarket trading, slipping to $22.37 from Wednesday's close of $22.44, as investors reacted to the announced CFO transition and ongoing fiber network costs. CFO Pascal Desroches will retire at year-end, succeeded by Jennifer Biry starting January 2027. The company aims to sustain free cash flow above $18 billion in 2026 despite heavy capital expenditure, including $5.1 billion spent in Q1. Market weakness weighed on the stock amid broader U.S. index declines driven by rate hike apprehensions following Federal Reserve signals. AT&T plans to provide further financial updates on July 22 with its Q2 earnings release. Meanwhile, competitor Verizon is simplifying wireless plans and removing fees to enhance customer retention, intensifying competition in the U.S. telecom sector.

Latest articles

Kroger edges down after it sticks to 2026 guidance

Kroger edges down after it sticks to 2026 guidance

18 June 2026
Kroger shares fell about 3% in premarket trading after first-quarter adjusted profit missed estimates by a cent despite a sales beat, as margin pressure from price cuts and higher transport costs raised investor doubts about CEO Greg Foran’s strategy to win back shoppers from Walmart and Costco.
HIVE Digital shares jump in premarket after $220 million Bell-Cohere AI contract

HIVE Digital shares jump in premarket after $220 million Bell-Cohere AI contract

18 June 2026
HIVE Digital Technologies surged 11% in premarket trading after its BUZZ HPC unit landed a $220 million, three-year GPU cloud contract with Bell AI Fabric and Cohere, expected to add $70 million in annual recurring revenue and boost contracted AI-compute revenue above $100 million, as investors look for growth beyond bitcoin mining.
AT&T falls in early trading on CFO transition, spotlight on fiber costs

AT&T falls in early trading on CFO transition, spotlight on fiber costs

18 June 2026
AT&T shares slipped to $22.37 premarket as investors weighed CFO Pascal Desroches’ year-end retirement and Jennifer Biry’s 2027 succession amid heavy fiber and 5G spending, ongoing wireless competition from Verizon, and looming risks from SpaceX’s Starlink; next financial update set for July 22.
Go toTop